Novel Corona Virus (nCOVID-19; India): Chain Reaction Disease (CRD); Precaution-Prevention, Treatment A Review
Santosh A. Jadhav *
Department of Chemistry, Vivekanand Arts S. D. Commerce and Science College, Aurangabad (MS), 431001, India.
Mahesh G. Shioorkar
Department of Chemistry, Vivekanand Arts S. D. Commerce and Science College, Aurangabad (MS), 431001, India.
Omprakash S. Chavan
Department of Chemistry, Badrinarayan Barwale College, Jalna (MS), 431132, India.
Sunil G. Sabhadinde
Department of Chemistry, Govt. Polytechnic, Ambad, Dist. Jalna (MS), 431209, India.
Sangram B. Sonje
Department of Botany, Vivekanand Arts S. D. Commerce and Science College, Aurangabad (MS), 431001, India.
Devanand B. Shinde
Shivaji University, Vidya Nagar, Kolhapur, (MS), 416004, India.
*Author to whom correspondence should be addressed.
Abstract
Corona virus-2 (nCOVID-19), causes respiratory infection including cold, fever, sneezing and coughing, pneumonia, headache, diarrhea and upper respiratory diseases. It transmitted human to human via airborne droplets. Corona virus enters in human cell through membrane ACE-2 exopeptidase receptor. Corona virus (CV) previously it treated as non-fatal virus (NFV), HCoV-NH, SARS and MERS-CoV and SARS-CoV. It was first isolated from Wuhan market China at December 2019, in world thus its name nCOVID-19. It is a Chain Reaction Disease (CRD) because of tremendously spread through contact human to human. WHO and ECDC advised to avoid public place - social distance and close contact (person-person) to infected persons, airborne droplet through sneezing and coughing. Some precautions, preventions and treatment of formerly synthesized anti-malarial, anti-biotic and anti-inflammatory etc drug used on novel corona virus disease.
Keywords: Flue influenza (FE) (1918), flu-like symptoms - CoV (1960), HCoV-NH, MERS-CoV, corona virus or SARS-CoV (2002-2005, 2012-2013), nCOVID-19 (2019), nCOVID-20(2020), chain reaction disease (CRD), treatment and precautions, prevention, India.